PUBLISHER: The Insight Partners | PRODUCT CODE: 1715170
PUBLISHER: The Insight Partners | PRODUCT CODE: 1715170
The Middle East & Africa medical exoskeleton market was valued at US$ 14.19 million in 2023 and is expected to reach US$ 98.25 million by 2031; it is estimated to register a CAGR of 27.4% from 2023 to 2031.
Increasing Technological Advancements and Rising Investments Bolster Middle East & Africa Medical Exoskeleton Market
Globally, people strive for better health and do not compromise with low-quality products. Owing to this, continuous technological developments and innovations are being made in the healthcare industry to enhance healthcare services and improve the quality of care. Various global market players are attempting to acquire a larger market share by increasing investments in exoskeleton systems on a global level. For instance, Exoskeleton maker RoboCT Technology Development Co. completed a US$ 15.7 million (RMB 100 million) Series A+ financing round in April 2022. RoboCT (headquartered in Hangzhou, China) provides smart rehabilitation devices and robotic technology, coupled with data analysis and cloud computing, to medical rehabilitation institutes for addressing the needs of elderly people and disabled individuals. In addition, growing R&D activities by companies operating in the market are anticipated to accelerate the development of advanced systems in various application areas. The companies also hold their technology and intellectual property rights that help them retain their market share.
Medical exoskeletons are likely to grow dramatically due to increasing revolutionary technology, innovative products, and successful events. Thus, companies manufacturing exoskeleton systems are expected to add value and attract wide customer base. The increased adoption of artificial intelligence (AI) and Internet of Things in developing intelligent exoskeleton systems is expected to complement the market growth. For instance, German Bionic has developed an AI-based exoskeleton system that has added a smart safety companion and a cloud-based platform for exoskeletons. Thus, the increasing technological advancements and rising investments are likely to catalyze the growth of the Middle East & Africa medical exoskeleton market during the forecast period.
Middle East & Africa Medical Exoskeleton Market Overview
Israel, Iran, Iraq, Kuwait, Oman, Egypt, and Kenya are among the major countries contributing to the medical exoskeleton market in The Rest of Middle East and Africa. Healthcare facilities across the aforementioned countries are focusing on developing healthcare infrastructure by adopting various advanced technologies, including medical exoskeleton, for rehabilitation of stroke, spinal cord injury, and other neurodegenerative disorders. Apart from addressing the needs of a large patient pool, the adoption of medical exoskeleton is further amplified due to their uptake in defense and industrial applications.
Middle East & Africa Medical Exoskeleton Market Revenue and Forecast to 2031 (US$ Million)
Middle East & Africa Medical Exoskeleton Market Segmentation
The Middle East & Africa medical exoskeleton market is categorized into component, type, extremity, application, mobility, end users, and country.
By component, the Middle East & Africa medical exoskeleton market is bifurcated into hardware and software. The hardware segment held a larger share of the Middle East & Africa medical exoskeleton market share in 2023.
In terms of type, the Middle East & Africa medical exoskeleton market is segmented into powered exoskeleton and passive exoskeleton. The powered exoskeleton segment held a larger share of the Middle East & Africa medical exoskeleton market share in 2023.
Based on extremity, the Middle East & Africa medical exoskeleton market is segmented into lower body exoskeleton, upper body exoskeleton, and full body exoskeleton. The lower body exoskeleton segment held the largest share of the Middle East & Africa medical exoskeleton market share in 2023.
By application, the Middle East & Africa medical exoskeleton market is segmented into spinal cord injury, multiple sclerosis, stroke, cerebral palsy, Parkinson's Disease, and others. The spinal cord injury segment held the largest share of the Middle East & Africa medical exoskeleton market share in 2023.
In terms of mobility, the Middle East & Africa medical exoskeleton market is bifurcated into mobile exoskeleton and stationary exoskeleton. The powered exoskeleton segment held a larger share of the Middle East & Africa medical exoskeleton market share in 2023.
By end users, the Middle East & Africa medical exoskeleton market is segmented into rehabilitation centers, physiotherapy centers, long term care centers, homecare settings, and others. The rehabilitation centers segment held the largest share of the Middle East & Africa medical exoskeleton market share in 2023.
Based on country, the Middle East & Africa medical exoskeleton market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. The Rest of Middle East & Africa segment held the largest share of Middle East & Africa medical exoskeleton market in 2023.
BIONIK; Cyberdyne Inc; Ekso Bionics Holdings Inc; Hocoma AG; Lifeward, Inc; and Rex Bionics Ltd. are some of the leading companies operating in the Middle East & Africa medical exoskeleton market.